Updated immunization schedule presented for adults for 2024
Jan 11, 2024
The changes include a recommendation for all adults to receive a dose of the new COVID-19 vaccine and RSV vaccination.
Bivalent COVID-19 shot effective for preventing thromboembolic events
Jan 11, 2024
The findings were seen for adults aged 65 years and older and for those aged 18 years and older with end-stage renal disease.
Virologic rebound occurs in ~20 percent receiving nirmatrelvir-nitonavir
Nov 14, 2023
Virologic rebound was more common among those who started therapy within two days of symptom onset.
Paxlovid not helpful for reducing most post-COVID-19 conditions
Oct 31, 2023
No differences were seen in most post-COVID-19 conditions examined individually or by organ system, apart from a lower combined risk for venous thromboembolism and pulmonary embolism.
COVID-19 meds like Paxlovid will soon have big price tags
Oct 30, 2023
The pills still will be available at no cost until those bought earlier by the federal government run out.
Plasma from convalescent donors beneficial for COVID-19-induced ARDS
Oct 30, 2023
Plasma with neutralizing antibody titer of at least 1:160 reduces mortality at 28 days versus standard care.
Unique workplace concerns tied to health worker depression, anxiety during pandemic
Oct 25, 2023
Associations were seen for working on the hospital unit, mood disturbances and sleep disturbances with depression and anxiety.
Autoimmune, autoinflammatory connective tissue disorders increased after COVID-19
Oct 10, 2023
The risks were associated with COVID-19 severity.
Severe SARS-CoV-2 appears to infect coronary vessels
Oct 05, 2023
SARS-CoV-2 targets plaque macrophages, and its entry is increased in cholesterol-loaded primary macrophages.
Nobel Prize for medicine awarded to COVID-19 vaccine pioneers
Oct 02, 2023
The prize panel said that their discovery ‘fundamentally changed our understanding of how mRNA interacts with our immune system.’